June 2025

 

Welcome to the latest edition of the Lymphoma Australia Newsletter

Inside this edition, we will be covering the following topics:

  • Dollar Matching Day for Dry July
  • Upcoming Support Groups
  • What’s new in Mantle Cell Lymphoma WEBINAR
  • Navigating Fertility & Menopause Through Treatment WEBINAR
  • Exercise & Lymphoma Webinar Recording
  • CAR T-CELL Therapy & Bispecific Antibodies Recording
  • Patient Stories: Andrew Warden
  • Winter Safety
  • Lymphoma Awareness Month
  • Gloup Medication
  • Fact sheets for you
  • Nurse Support Line 1800 953 081

 

CLICK HERE to read more.

Share This

Contact Lymphoma Australia Today!

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.